Azur Sues Barr Over Plan To Make Generic FazaClo

Law360, New York (August 25, 2008, 12:00 AM EDT) -- CIMA Labs Inc. and Irish drugmaker Azur Pharma Ltd. have sued generics rival Barr Pharmaceuticals Inc. over its plan to make a generic version of Azur's anti-psychotic drug FazaClo, saying the drug would infringe patents Azur licenses from CIMA.

According to the plaintiffs' complaint, filed Thursday in the U.S. District Court for the District of Delaware, Barr told Azur and CIMA last month that it had filed an abbreviated new drug application with the U.S. Food and Drug administration to make orally disintegrating tablets containing 25...
To view the full article, register now.